Summary
Our experience on the study of IFN receptor and signals associated with the response in the treatment of chronic hepatitis C (CHC) was described.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Uze G, Lutfalla G, Gresser. Genetic transfer of a functional human interferon -a receptor into mouse cells: cloning and expression of its cDNA. Cell 1990;60:225–234.
Novick D, Cohen B, Rubinstein M. The human interferon-a/ß receptor: characterization and molecular cloning. Cell 1994;77:391–400.
Domanski P, Witte M, Kellum M, Rubinstein M, Hackett R, Pitha P, Colamonici OR. Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J Biol Chem 1995;270:21606–11.
Pfeffer LM, Basu L, Pfeffer SR, Yang CH, Murti A, Russell-Harde D, Croze E. The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action. J Biol Chem 1997;272:11002–5.
Mizukoshi E, Kaneko S, Kaji K, Terasaki S, Matsushita E, Muraguchi M, Ohmoto Y, Kobayashi K. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C. Hepatology 1999;30:1325–31.
Han CS, Chen Y, Ezashi T, Roberts RM. Antiviral activities of the soluble extracellular domains of type I interferon receptors. Proc Natl Acad Sci USA 2001;98:6138–43.
Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: Relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol 1999;30:995–1003.
Navarro S, Colamonici OR, Llombart-Bosch A. Immunohistochemical detection of the type I interferon receptor in human fetal, adult, and neoplastic tissues. Mod Pathol 1996;9:150–156.
Volpes R, van den Oord JJ, De Vos R, Depla E, De Ley M, Desmet VJ. Expression of interferon-gamma receptor in normal and pathological human liver tissue. J Hepatol 1991;12:195–202.
Ishimura N, Fukuda R, Fukumoto S. Relationship between intrahepatic expression of interferon-a receptor mRNA and the histological progress of hepatitis C virus-associated chronic liver diseases. J Gastroenterol Hepatol 1996;11:712–717.
Miyajima I, Sata M, Gondo K, Suzuki H, Tanigawa K. Interferon accumulation in cirrhotic rat liver. J Vir Hepat 1996;3:23–27.
David M. Signal transduction by type I interferons. Biotechniques 2002;Suppl:58–65.
Borden EC. Gene regulation and clinical roles for interferons in neoplastic diseases. Oncologist 1998;3:198–203.
Harada H, Taniguchi T, Tanaka N. The role of interferon regulatory factors in the interferon system and cell growth control. Biochimie 1998;80:641–50.
Kalvakolanu DV. Virus interception of cytokine-regulated pathways. Trends Microbiol 1999;7:166–71.
Yasukawa H, Misawa H, Sakamoto H, Masuhara M, Sasaki A, Wakioka T, Ohtsuka S, Imaizumi T, Matsuda T, Ihle JN, Yoshimura A. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 1999;18:1309–20.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Japan
About this paper
Cite this paper
Yatsuhashi, H. (2004). IFN Receptor and IFN Signals. In: Omata, M., Okita, K. (eds) Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-53977-3_17
Download citation
DOI: https://doi.org/10.1007/978-4-431-53977-3_17
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-67975-2
Online ISBN: 978-4-431-53977-3
eBook Packages: Springer Book Archive